CRP and rheumatoid arthritis: However, ESR and CRP show limited specificity and sensitivity as biomarkers for monitoring RA disease activity, especially in patients taking cytokine blocking agents11,12; therefore, there is great interest in identifying alternative and reliable biomarkers that can improve the assessment of treatment responses.